In addition, there was an increased CD69+ NKcell percentage in the presence plasma-derived exosomeof responsive DLBCL patients plus IL-2/IL-15 comparedto the absence of exosomes in responsive DLBCL patientsand healthy donors (P=0.0001 and P=0.022, respectively,LSD Post-Hoc). The gene discussed is IL2; the disease is diffuse large B-cell lymphoma.